BRGX (BioRegenx) Machinery, Furniture, Equipment : $0.00 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx Machinery, Furniture, Equipment?

BioRegenx's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2024 was $0.00 Mil.

BioRegenx's quarterly Machinery, Furniture, Equipment declined from Jun. 2024 ($0.23 Mil) to Sep. 2024 ($0.21 Mil) and declined from Sep. 2024 ($0.21 Mil) to Dec. 2024 ($0.00 Mil).

BioRegenx Machinery, Furniture, Equipment Historical Data

The historical data trend for BioRegenx's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Machinery, Furniture, Equipment Chart

BioRegenx Annual Data

Trend

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

BioRegenx Quarterly Data
	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															-	0.58	0.23	0.21	-

BioRegenx Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

BioRegenx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

7407 Ziegler Road, Chattanooga, TN, USA, 37421

Website

https://www.bioregenx.com

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.